|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Entrada Therapeutics, Inc. (TRDA) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
16 |
|
|
Total
Direct Shares :
|
882,230 |
|
Total
Indirect Shares :
|
29,548,952 |
|
%
Held by Insiders:
|
2.83% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Doshi Dipal |
CEO, Director |
2024-03-05 |
340,375 |
|
0 |
Sethuraman Natarajan |
Chief Scientific Officer |
2024-03-05 |
209,032 |
|
0 |
Dowden Nathan J |
President & COO |
2024-03-06 |
137,204 |
|
0 |
Wentworth Kory James |
Chief Financial Officer |
2024-03-15 |
83,170 |
|
0 |
Kim Peter S |
Director |
2024-05-09 |
67,412 |
|
0 |
Schwab Andrew J. |
10% Owner |
|
0 |
2021-11-02 |
1,132,357 |
Parmar Kush |
Director, 10% Owner |
|
0 |
2021-11-02 |
1,132,357 |
Foley Todd |
Director, 10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
Mpm Bioventures 2018 Gp Llc |
10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
Roche Finance Ltd |
10% Owner |
2021-11-02 |
0 |
2021-11-02 |
2,813,525 |
Redmile Biopharma Investments Iii, L.p. |
10% Owner |
2021-11-02 |
0 |
2021-11-02 |
1,954,420 |
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
2021-11-02 |
0 |
2021-11-02 |
4,425,784 |
Baker Julian |
10% Owner |
|
0 |
2021-12-14 |
4,704,419 |
Kreher Nerissa |
Chief Medical Officer |
2023-09-06 |
40,037 |
2021-12-29 |
0 |
Crowley John F |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Baker Bros. Advisors (gp) Llc |
10% Owner |
2022-05-16 |
0 |
2022-06-06 |
4,501,658 |
|
|